Liquidia (LQDA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $34.78, +2.47% vs the prior close of $33.94.
- Volume 7.22M shares, 2.1x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
LQDA rises 2.5% to $34.78 on 2.1x normal volume. Closed at $34.78, +2.47% vs the prior close of $33.94. Day range $32.20–$35.80, opened at $34.93.
LQDA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LQDA rises 2.5% to $34.78 on 2.1x normal volume
- Closed at $34.78, +2.47% vs the prior close of $33.94. Day range $32.20–$35.80, opened at $34.93.
- Volume was 7.22M shares, 2.1x its 50-day average of 3.39M — unusually heavy trading.
- Price is -43.6% vs its 50-day average ($61.62) and -35.5% vs its 200-day average ($53.93).
- 52-week range $21.94–$93.61; today's close sits at 18% of that range, 62.8% below the 52-week high.
Oct 14, 2026 — LQDA jumps 26.6% to $33.94 on 7.1x normal volume
- Closed at $33.94, +26.59% vs the prior close of $26.81. Day range $33.12–$38.64, opened at $35.70.
- Volume was 21.14M shares, 7.1x its 50-day average of 2.99M — unusually heavy trading.
- Price is -45.9% vs its 50-day average ($62.71) and -37.1% vs its 200-day average ($53.93).
- 52-week range $21.94–$93.61; today's close sits at 17% of that range, 63.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — LQDA slides 3.1% to $26.81 on 2.7x normal volume
- Closed at $26.81, -3.11% vs the prior close of $27.67. Day range $26.13–$27.40, opened at $27.04.
- Volume was 7.65M shares, 2.7x its 50-day average of 2.86M — unusually heavy trading.
- Price is -58.0% vs its 50-day average ($63.80) and -50.3% vs its 200-day average ($53.93).
- 52-week range $21.94–$93.61; today's close sits at 7% of that range, 71.4% below the 52-week high.
Oct 12, 2026 — LQDA rises 1.1% to $27.67
- Closed at $27.67, +1.06% vs the prior close of $27.38. Day range $27.28–$30.86, opened at $29.27.
- Volume was 4.41M shares, 1.6x its 50-day average of 2.79M.
- Price is -57.4% vs its 50-day average ($64.94) and -48.7% vs its 200-day average ($53.97).
- 52-week range $21.94–$93.61; today's close sits at 8% of that range, 70.4% below the 52-week high.
Oct 9, 2026 — LQDA dips 2.3% to $27.38
- Closed at $27.38, -2.28% vs the prior close of $28.02. Day range $26.67–$28.53, opened at $27.06.
- Volume was 3.62M shares, 1.3x its 50-day average of 2.75M.
- Price is -58.6% vs its 50-day average ($66.07) and -49.3% vs its 200-day average ($54.01).
- 52-week range $21.94–$93.61; today's close sits at 8% of that range, 70.8% below the 52-week high.
Oct 8, 2026 — LQDA jumps 5.0% to $28.02 on 2.0x normal volume
- Closed at $28.02, +5.02% vs the prior close of $26.68. Day range $26.34–$29.35, opened at $26.34.
- Volume was 5.26M shares, 2.0x its 50-day average of 2.67M — unusually heavy trading.
- Price is -58.3% vs its 50-day average ($67.25) and -48.2% vs its 200-day average ($54.05).
- 52-week range $21.94–$93.61; today's close sits at 8% of that range, 70.1% below the 52-week high.
Oct 7, 2026 — LQDA rises 3.0% to $26.68 on 2.7x normal volume
- Closed at $26.68, +2.97% vs the prior close of $25.91. Day range $24.59–$27.33, opened at $25.55.
- Volume was 6.98M shares, 2.7x its 50-day average of 2.55M — unusually heavy trading.
- Price is -61.0% vs its 50-day average ($68.43) and -50.7% vs its 200-day average ($54.08).
- 52-week range $21.94–$93.61; today's close sits at 7% of that range, 71.5% below the 52-week high.
Oct 6, 2026 — LQDA slides 6.3% to $25.91, a 6-month low on 2.1x normal volume
- Closed at $25.91, -6.26% vs the prior close of $27.64. Day range $25.76–$28.30, opened at $27.95.
- Volume was 5.31M shares, 2.1x its 50-day average of 2.47M — unusually heavy trading.
- Price is -62.8% vs its 50-day average ($69.63) and -52.1% vs its 200-day average ($54.12).
- 52-week range $21.94–$93.61; today's close sits at 6% of that range, 72.3% below the 52-week high.
Oct 5, 2026 — LQDA slides 3.5% to $27.64, a 6-month low on 3.3x normal volume
- Closed at $27.64, -3.49% vs the prior close of $28.64. Day range $25.92–$28.48, opened at $28.07.
- Volume was 7.76M shares, 3.3x its 50-day average of 2.35M — unusually heavy trading.
- Price is -61.0% vs its 50-day average ($70.80) and -49.0% vs its 200-day average ($54.16).
- 52-week range $21.91–$93.61; today's close sits at 8% of that range, 70.5% below the 52-week high.
Oct 2, 2026 — LQDA rises 2.3% to $28.64 on 3.8x normal volume
- Closed at $28.64, +2.32% vs the prior close of $27.99. Day range $26.31–$29.18, opened at $26.69.
- Volume was 8.39M shares, 3.8x its 50-day average of 2.22M — unusually heavy trading.
- Price is -60.2% vs its 50-day average ($71.97) and -47.2% vs its 200-day average ($54.20).
- 52-week range $21.35–$93.61; today's close sits at 10% of that range, 69.4% below the 52-week high.
LQDA latest news & SEC filings
Every SEC filing by or about LQDA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schundler Russell converted options/RSUs into 3,758 shares on Oct 9, 2026; now holds 610,124
- Schundler Russell converted options/RSUs into 6,409 shares on Oct 9, 2026; now holds 616,533
- Schundler Russell sold 13,692 shares at $28.48 (≈$389.95K) on Oct 12, 2026; now holds 602,841
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saggar Rajeev converted options/RSUs into 3,530 shares on Oct 9, 2026; now holds 131,100
- Saggar Rajeev converted options/RSUs into 4,486 shares on Oct 9, 2026; now holds 135,586
- Saggar Rajeev sold 9,218 shares at $28.48 (≈$262.53K) on Oct 12, 2026; now holds 126,368
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Moomaw Scott converted options/RSUs into 3,108 shares on Oct 9, 2026; now holds 185,992
- Moomaw Scott converted options/RSUs into 4,358 shares on Oct 9, 2026; now holds 190,350
- Moomaw Scott sold 8,863 shares at $28.48 (≈$252.42K) on Oct 12, 2026; now holds 181,487
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Krepp Sarah converted options/RSUs into 3,178 shares on Oct 9, 2026; now holds 120,486
- Krepp Sarah sold 5,245 shares at $28.48 (≈$149.38K) on Oct 12, 2026; now holds 115,241
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Khindri Sanjeev sold 1,101 shares at $28.48 (≈$31.36K) on Oct 12, 2026; now holds 64,846
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kaseta Michael converted options/RSUs into 5,828 shares on Oct 9, 2026; now holds 352,037
- Kaseta Michael converted options/RSUs into 7,049 shares on Oct 9, 2026; now holds 359,086
- Kaseta Michael sold 18,938 shares at $28.48 (≈$539.35K) on Oct 12, 2026; now holds 340,148
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $171.68M (prior year $8.84M) (+1842.7% vs Jun 30, 2025)
- Net income: $74.72M (prior year -$41.58M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.74 (prior year -$0.49) (swung to profit vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade LQDA
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 5, 2026, Nov 3, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.43% (largest 57.2%). That is a volatile stock.
- Liquidity: about 6.69M shares (≈$232.70M) trade per day on average.
- 52-week position: $34.78 vs a range of $21.94–$93.61 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Raman Singh sold 8,468 shares on Sep 14, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 30, 2026; 8-K Sep 3, 2026.
- Share count: 89.51M shares outstanding (Jul 29, 2026), +4.0% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LQDA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 34.93 | 35.80 | 32.20 | 34.78 | 7.22M |
| Oct 14, 2026 | 35.70 | 38.64 | 33.12 | 33.94 | 21.14M |
| Oct 13, 2026 | 27.04 | 27.40 | 26.13 | 26.81 | 7.65M |
| Oct 12, 2026 | 29.27 | 30.86 | 27.28 | 27.67 | 4.41M |
| Oct 9, 2026 | 27.06 | 28.53 | 26.67 | 27.38 | 3.62M |
| Oct 8, 2026 | 26.34 | 29.35 | 26.34 | 28.02 | 5.26M |
| Oct 7, 2026 | 25.55 | 27.33 | 24.59 | 26.68 | 6.98M |
| Oct 6, 2026 | 27.95 | 28.30 | 25.76 | 25.91 | 5.31M |
| Oct 5, 2026 | 28.07 | 28.48 | 25.92 | 27.64 | 7.76M |
| Oct 2, 2026 | 26.69 | 29.18 | 26.31 | 28.64 | 8.39M |
| Oct 1, 2026 | 23.96 | 28.10 | 22.31 | 27.99 | 21.57M |
| Sep 30, 2026 | 70.54 | 71.93 | 29.86 | 30.26 | 22.95M |
| Sep 29, 2026 | 72.49 | 73.15 | 68.74 | 70.69 | 1.53M |
| Sep 28, 2026 | 68.05 | 74.74 | 67.66 | 73.67 | 1.21M |
| Sep 25, 2026 | 71.60 | 71.81 | 67.55 | 68.43 | 967.30K |
| Sep 24, 2026 | 67.04 | 71.41 | 66.75 | 70.95 | 1.03M |
| Sep 23, 2026 | 68.60 | 68.60 | 67.10 | 67.49 | 765.90K |
| Sep 22, 2026 | 66.59 | 68.76 | 66.00 | 68.64 | 1.14M |
| Sep 21, 2026 | 67.18 | 67.41 | 65.74 | 66.43 | 1.01M |
| Sep 18, 2026 | 68.08 | 68.72 | 66.57 | 66.88 | 3.90M |
About Liquidia
Liquidia (LQDA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MORRISVILLE, NC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1819576.
LQDA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Stephen M Bloch | Director | Jul 24, 2026 |
| Partners Lp Caligan | See Remarks. | Jun 18, 2026 |
| Joanna Horobin | Director | Jun 18, 2026 |
| Roger Jeffs | Chief Executive Officer | Jul 14, 2026 |
| David Edward Johnson | Director | Jun 18, 2026 |
| Arthur S Kirsch | Director | Jun 18, 2026 |
| Paul B Manning | Director | Jun 18, 2026 |
| Katherine Rielly-Gauvin | Director | Aug 21, 2026 |
| Raman Singh | Director | Sep 15, 2026 |
| Damian Degoa | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jason Adair | Chief Business Officer | Aug 25, 2026 |
| Dana Boyle | Chief Accounting Officer | Jul 29, 2026 |
| Roger Jeffs | Chief Executive Officer | Jul 14, 2026 |
| Michael Kaseta | CFO and COO | Jul 14, 2026 |
| Sanjeev Khindri | Chief Development Officer | Jul 14, 2026 |
| Sarah Krepp | Chief Human Resource Officer | Sep 3, 2026 |
| Scott Moomaw | Chief Commercial Officer | Jul 14, 2026 |
| Rajeev Saggar | Chief Medical Officer | Aug 19, 2026 |
| Russell Schundler | General Counsel | Jul 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Raman Singh | Sale | 8,468 | $66.16 |
| Sep 11, 2026 | Raman Singh | Sale | 9,024 | $68.62 |
| Sep 1, 2026 | Sarah Krepp | Sale | 274 | $67.76 |
| Aug 21, 2026 | Jason Adair | Sale | 41,832 | $69.09 |
| Aug 21, 2026 | Jason Adair | Sale | 31,799 | $69.09 |
| Aug 20, 2026 | Katherine Rielly-Gauvin | Sale | 18,393 | $72.23 |
| Aug 19, 2026 | Katherine Rielly-Gauvin | Sale | 36,789 | $74.99 |
| Aug 19, 2026 | Rajeev Saggar | Sale | 50,000 | $74.06 |
| Aug 17, 2026 | Rajeev Saggar | Sale | 29,534 | $76.84 |
| Jul 27, 2026 | Dana Boyle | Sale | 1,600 | $87.53 |
| Jul 27, 2026 | Jason Adair | Sale | 688 | $87.53 |
| Jul 23, 2026 | Stephen M Bloch | Sale | 3,600 | $90.71 |
| Jul 23, 2026 | Stephen M Bloch | Sale | 96,400 | $89.44 |
| Jul 22, 2026 | Stephen M Bloch | Sale | 37,406 | $87.70 |
| Jul 22, 2026 | Stephen M Bloch | Sale | 48,032 | $88.65 |
LQDA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $158.32M | $-68.92M | -0.80 | $-35.69M |
| Dec 31, 2024 | $14.00M | $-128.29M | -1.63 | $-93.42M |
| Dec 31, 2023 | $17.49M | $-78.50M | -1.21 | $-41.56M |
| Dec 31, 2022 | $15.94M | $-41.02M | -0.67 | $-28.59M |
| Dec 31, 2021 | $12.85M | $-34.58M | -0.70 | $-34.03M |
Latest balance sheet: total assets $521.92M, total liabilities $326.80M, cash $284.18M (as of Jun 30, 2026).
LQDA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $78.79 |
| May 11, 2026 | 8-K Item 2.02 (results) | $53.13 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $34.52 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $25.22 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $24.10 |
| May 8, 2025 | 8-K Item 2.02 (results) | $15.35 |
| Mar 19, 2025 | 8-K Item 2.02 (results) | $14.92 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $10.27 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LQDA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.